Stereotaxis Announces Preliminary Third Quarter 2013 Financial Results in Preparation for Rights Offering

Stereotaxis, Inc. (STXS) today released certain preliminary financial results for the 2013 third quarter in anticipation of its previously announced rights offering of common stock, which is expected to commence in the near future.

Third Quarter 2013 Preliminary Financial Results:

• Total revenue of approximately $10.6 million to $11.1 million, with system revenue between $4.4 million and $4.6 million and recurring revenue of approximately $6.2 million to $6.5 million
• One new Niobe(R) system order added to backlog with an estimated ending capital backlog of $5.2 million to $5.6 million

  Published: 23 October 2013

  Written by Editor

  Nasdaq   Healthcare   Financial Results   Up on News   Interesting News  

  Read more: Stereotaxis Inc ( STXS )

Cardiovascular Systems, Inc. Receives Coronary FDA Approval

    Diamondback 360® Coronary Orbital Atherectomy System Approved to Treat Severely Calcified Coronary Lesions
    Controlled Commercial Launch to begin immediately

Cardiovascular Systems, Inc. (CSI) (CSII), today announced that it has received PMA approval from the U.S. Food and Drug Administration (FDA) to market its Diamondback 360^® Coronary Orbital Atherectomy System (OAS) as a treatment for severely calcified coronary arteries.

“Today is a landmark moment for: patients suffering from calcified coronary artery disease, their families, our physician operators and everyone at CSI,” said David L. Martin, President and Chief Executive Officer of Cardiovascular Systems. “FDA approval of our Diamondback 360 Coronary OAS allows us to bring to market the first new coronary atherectomy system in more than two decades.”

Align Technology Announces Third Quarter 2013 Results

Align Technology, Inc. (NASDAQ: ALGN)

• Net revenues of $164.5 million were up 20.5% year-over-year
• Invisalign clear aligner net revenues of $153.5 million were up 21.2% year-over-year
• Invisalign clear aligner shipments of 106.9 thousand were up 15.5% year-over-year
• GAAP earnings per diluted share (EPS) of $0.42

  Published: 18 October 2013

  Written by Editor

  Nasdaq   Healthcare   Financial Results   Up on News   Interesting News  

  Read more: Align Technology Inc ( ALGN )

IMRIS and Stryker are working to combine efforts to offer auto-registration with surgical navigation in VISIUS iCT & iMRI surgical theaters

Workflow will be streamlined in navigated spinal and cranial procedures performed in advanced intraoperative imaging suites

IMRIS Inc. ("IMRIS") and Stryker Corporation ("Stryker") today announced a non-exclusive collaboration between Stryker's automatic image registration for spinal and cranial navigated procedures and VISIUS^® iCT and VISIUS iMRI surgical suites from IMRIS.

"Having these tools work together is an exciting opportunity for surgeons utilizing intraoperative CT and MRI in our VISIUS^® Surgical Theatres. This open platform collaboration aligns squarely with our goal of providing state-of-the-art imaging at the point of therapy," said Jay D. Miller, IMRIS President and CEO.